Application in a Dehiscence Post Charcot Reconstruction – Exposed Bone and Joint

Richard Kaufman, DPM, CWSP

Piedmont Atlanta Hospital – Atlanta, GA
Intra-operative Defect
Post-op Week 12

Results

  • 100% epithelialized at week 12
  • No complications

Healed by secondary intention with Endoform

Patient details

52-year-old male

Medical history

Uncontrolled Diabetes Type 2 Charcot, Arthropathy, peripheral arterial disease

Case details

  • Description: Full thickness wound with deep sinus and exposed bone and joint
  • Etiology: Surgical dehiscence status post Triple Arthrodesis/Medial Column fusion with internal and external fixation
  • Plan: Surgical debridement, IV antibiotics

Application photos

Week 0 - Defect filled with Myriad Morcells and Myriad Matrix

  • Left ankle debridement with external fixator​
  • Applied Myriad Morcells (1000 mg) into deep tunnel with Myriad Matrix (5 x 5 cm, 3-Layer) overlay​
  • NPWT secondary dressing

Week 1

  • Graft well adhered​
  • No complications

Week 2

  • ​Robust granulation​
  • 100% depth filled ​
  • Covered exposed bone and joint​
  • No complications​
  • Plan for return to OR to remove external fixation, wound debridement and possible 2nd application of Myriad Matrix

Week 4

  • Myriad Matrix (5 x 5 cm, 3-Layer) well adhered​
  • No complications​
  • Discontinue NPWT, applied bolster secondary dressing

Week 6

  • Residual Myriad Matrix removed revealing 100% granular wound bed​
  • Defect filled with viable soft tissue​
  • Covered exposed bone and joint​
  • No complications​
  • Plan to heal by secondary intention with Endoform Natural

Week 10

  • 80% epithelialized
  • No complications
  • Continue to close via secondary intention with Endoform

Week 12

  • 100% epithelialized
  • No complications

Results may vary. Dr. Kaufman has a consultancy agreement with Aroa Biosurgery Limited.

Are you a Healthcare Professional?

The following content is intended for the information of health care professionals only.

Not all products or indications are licensed in every country.